Jose Manuel Baena-Cañada

7PUBLICATIONS
35CO-AUTHORS
Midwifery not elsewhere classifiedPredictive and prognostic markersModels of care and place of birthCancer therapy (excl. chemotherapy and radiation therapy)Aboriginal and Torres Strait Islander diet and nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 03, 2025
Comparison of clinical characteristics and survival between HER2-zero and HER2-low in early breast cancer: a retrospective observational study.

Violeta Núñez Álvarez, Belén González Castilla, Belén Fernández Rivero

|Jun 26, 2025
FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial.

Federico Rojo, Clive R Taylor, Carlos Barrios

|Mar 28, 2024
Clinicopathological and Genomic Identification of Breast Cancers with No Impact on Mortality.

Salvador Gámez-Casado, Lourdes Rodríguez-Pérez, Cristina Bandera-López

|May 03, 2023
Real world evidence of adjuvant trastuzumab in HER2 positive early breast cancer.

J Lluch-Gómez, V Núñez-Álvarez, C de la Torre-Hita

|Feb 23, 2022
Type does matter. Use VIRGIN olive oil as your preferred fat to reduce your risk of breast cancer: case-control EpiGEICAM study.

Carolina Donat-Vargas, Ángel Guerrero-Zotano, Virginia Lope

Pageof 2